Artificial tear / Lubricating ophthalmic solution

This page covers all Artificial tear / Lubricating ophthalmic solution drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ocular inflammation and discomfort.

Targets

Ocular inflammation and discomfort

Marketed (4)

• Tears Naturale II Ophthalmic Solution · ORA, Inc. · Ophthalmology
  Tears Naturale II is an artificial tear solution that lubricates and protects the ocular surface by mimicking natural tear composition.
• NAABAK eyedrops · Laboratoires Thea · Ophthalmology
• LiquiTears · Chakshu Research, Inc. · Ophthalmology
  LiquiTears is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms.
• OZODROP · University of Molise · Ophthalmology
  OZODROP is an ozone-based ophthalmic solution that delivers therapeutic ozone to the ocular surface.

Phase 3 pipeline (2)

• OTX-101 0.09% · Sun Pharmaceutical Industries Limited · Ophthalmology
  OTX-101 is a topical ophthalmic solution used to treat dry eye disease.
• SJP-0035 0.001% · Senju Pharmaceutical Co., Ltd. · Ophthalmology
  SJP-0035 is a topical ophthalmic solution used to treat dry eye disease.

Patent intelligence

• ophthalmic solution patent landscape — aggregated cliff calendar, attackable patents, originator estates